Optimer Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing innovative hospital specialty products that have a positive impact on society. We focus on medicines that make a significant difference in the lives of patients and reduce the burden of disease.
DIFICID (fidaxomicin) tablets, an antibacterial drug, is the first drug indicated in adults (> 18 years of age) for Clostridium difficile-associated diarrhea to be approved by FDA in over 25 years.
Optimer® is building its team of professionals who share our vision to develop and commercialize innovative hospital specialty products that have a positive impact on society
Learn about our Investigator Initiated Study program
The DIFICID Rx Assist Program supports patient access to DIFICID® (fidaxomicin) tablets